Brady Martz Wealth Solutions’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.22M Buy
6,139
+136
+2% +$46.6K 0.34% 69
2026
Q1
$2.11M Buy
6,003
+1,064
+22% +$379K 0.36% 64
2025
Q4
$1.62M Buy
4,939
+343
+7% +$109K 0.28% 68
2025
Q3
$1.3M Buy
4,596
+25
+0.5% +$7.25K 0.24% 78
2025
Q2
$1.28M Sell
4,571
-48
-1% -$13.6K 0.25% 76
2025
Q1
$1.44M Sell
4,619
-43
-0.9% -$12.7K 0.33% 66
2024
Q4
$1.25M Buy
+4,662
New +$1.38M 0.3% 72

Other funds holding AMGN

Brady Martz Wealth Solutions's AMGN Position: Q2 2026 in Review

Brady Martz Wealth Solutions increased its Amgen (AMGN) stake by 2.3% in Q2 2026, buying an estimated $46.6K and bringing the position to 6,139 shares worth $2.22M. The position accounts for 0.34% of the portfolio, ranked #69.

Brady Martz Wealth Solutions first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 1,055 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Brady Martz Wealth Solutions held 6,139 shares of Amgen worth $2.22M as of Q2 2026.
  • Brady Martz Wealth Solutions bought 136 Amgen shares in Q2 2026, an estimated $46.6K.
  • Amgen made up 0.34% of Brady Martz Wealth Solutions's portfolio in Q2 2026, its #69 holding.
  • Brady Martz Wealth Solutions first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • 1,055 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Brady Martz Wealth Solutions's 13F filing for Q2 2026, filed 23 Jul 2026.